.

Puma Biotechnology reported $47.52M in Operating Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Agios Pharmaceuticals AGIO:US $ 100.52M 1.24M
Alnylam Pharmaceuticals ALNY:US $ 416.5M 56.51M
Amgen AMGN:US $ 4.42B 680M
Biogen BIIB:US $ 2648.2M 727.1M
Biomarin Pharmaceutical BMRN:US $ 494.65M 112.61M
Bluebird Bio BLUE:US $ 108.92M 13.37M
Cerulean Pharma CERU:US $ 8.4M 1.14M
Clovis Oncology CLVS:US $ 91.52M 6.92M
Daiichi Sankyo 4568:JP 245.94B 38.74B
Esperion Therapeutics ESPR:US $ 71.22M 9.39M
Exelixis EXEL:US $ 335.72M 62.98M
Gilead Sciences GILD:US $ 4231M 2162M
Glaxosmithkline GSK:US 5.85B 1.13B
Intercept Pharmaceuticals ICPT:US $ 85.12M 13.73M
Macrogenics MGNX:US $ 67.82M 9.92M
Mirati Therapeutics MRTX:US $ 182.57M 2.36M
Moderna Inc MRNA:US 2.3B 463M
Novartis NOVN:VX 10.86B 895M
Pfizer PFE:US $ 15640M 148M
Ptc Therapeutics PTCT:US $ 257.89M 22.63M
Puma Biotechnology PBYI:US $ 47.52M 1.01M
Regeneron Pharmaceuticals REGN:US $ 1747.3M 40.7M
Sangamo Biosciences SGMO:US $ 75.11M 1.62M
Sarepta Therapeutics SRPT:US $ 444.62M 146.91M
Seattle Genetics SGEN:US $ 630.61M 71.1M
Spectrum Pharmaceuticals SPPI:US $ 25.39M 11.33M
Takeda 4502:JP 821.95B 52.96B
Tg Therapeutics TGTX:US $ 39.53M 29.35M
Ultragenyx Pharmaceutical RARE:US $ 230.94M 14.37M
Vanda Pharmaceuticals VNDA:US $ 60.93M 6.93M
Vertex Pharmaceuticals VRTX:US $ 1089.9M 33.3M
YTE INCY:US $ 656.97M 40.27M